Marc Struhalla

c-LEcta GmbH operates as a industrial biotechnology company that discovers, optimizes, produces, and sells enzymes for research, development, bio-catalysis, diagnostics, and industrial applications. The firm focuses on the utilization of proteins with catalytic properties. It offers recombinant RNases, exonucleases, alcohol-dehydrogenases, lipases, and proteases for applications in research and development; biocatalysts for the production of chemicals; and starch, cellulose, and hemicellulose hydrolyzing enzymes, as well as lipases and proteases to use as components in detergents and cleaning products for the food and feed industry. The company was founded by Marc Struhalla and Thomas Greiner-St?ffele in 2004 and is headquartered in Leipzig, Germany.